Elevated BCRP Transporter and Altered NF‐кB Pathway Mediate Zoledronic Acid Resistance in MCF‐7 Cells
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Öykü Irmak Dikkatli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Institute of Science, Başkent University, Ankara, Türkiye. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily G, Member 2, Zoledronic Acid, Neoplasm Proteins, NF-kappa B. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: This study was supported by The Scientific and Technological Research Council of Türkiye (TUBİTAK) with project number 121Z039..
Abstract (Originalsprache)
Zoledronic acid (ZA), a bisphosphonate derivate, became the standard for preserving bone structure in cancer. Using various intracellular signaling pathways, including NF‐κB, ZA inhibits tumor cell proliferation, induces apoptosis, and has additive and synergistic effects with cytotoxic agents. However, it has been observed that resistance has developed against ZA. This study aims to explore the underlying mechanisms of ZA resistance in MCF‐7 breast cancer cells by investigating the activity and localization of the human breast cancer resistance protein (BCRP), changes in the NF‐κB pathway, and the markers of epithelial‐mesenchymal transition (EMT). Previously, MCF‐7 cells were stepwise selected in increasing concentrations of ZA and became resistant to 8 µM ZA (MCF‐7/Zol). We determined that BCRP levels were elevated with altered intracellular localization in ZA resistant MCF‐7 cells, and BCRP pump caused a decrease in the substrate accumulation in the MCF‐7/Zol cells whereas no change in intercellular substrate accumulation was observed in parental cells. MCF‐7/Zol cells have increased amount of phosphorylated IκB which is associated with increased nuclear translocation of NF‐κB. Concordantly, BCRP upregulation may be associated with increased nuclear NF‐κB in ZA resistant cells. MCF‐7/Zol cells did not harbor EMT markers. Elucidation of molecular mechanisms of resistance developed against chemotherapeutic agents is important to target critical pathways and proteins to eliminate the resistant clones as well as for determining biomarkers for MDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Institute of Science, Başkent University, Ankara, Türkiye.
- TENMAK, Boron Research Institute, Ankara, Türkiye.
- Department of Molecular Biology and Genetics, Faculty of Science and Letters, Başkent University, Ankara, Türkiye.
- Department of Medical Biology and Genetics, Faculty of Medicine, Maltepe University, İstanbul, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Türkiye.
ORCID-Profile: Öykü Irmak Dikkatli, Yunus Emre Cavlak, Yaprak Dönmez Çakıl, Sueda Atılkan, Erkan Yurtcu, Özlem Darcansoy İşeri
Förderung
- This study was supported by The Scientific and Technological Research Council of Türkiye (TUBİTAK) with project number 121Z039.
Zitieren
APA
Dikkatli, Ö. I., Cavlak, Y. E., Çakıl, Y. D., Atılkan, S., Yurtcu, E., & İşeri, Ö. D. (2025). Elevated BCRP Transporter and Altered NF‐кB Pathway Mediate Zoledronic Acid Resistance in MCF‐7 Cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70397
Vancouver
Dikkatli ÖI, Cavlak YE, Çakıl YD, Atılkan S, Yurtcu E, İşeri ÖD. Elevated BCRP Transporter and Altered NF‐кB Pathway Mediate Zoledronic Acid Resistance in MCF‐7 Cells. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70397
BibTeX
@article{Dikkatli2025,
author = {Dikkatli, Öykü Irmak and Cavlak, Yunus Emre and Çakıl, Yaprak Dönmez and Atılkan, Sueda and Yurtcu, Erkan and İşeri, Özlem Darcansoy},
title = {Elevated BCRP Transporter and Altered NF‐кB Pathway Mediate Zoledronic Acid Resistance in MCF‐7 Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70397}
}
EUVIMED